Stock overview
vVARDIS Holding AG
VVVV
Vvardis Holding AG is a disruptive Swiss healthcare company that engages in research and development as well as business activities to manufacture, sell and distribute dental care products. The company's proprietary peptide-enabled technology platform, Curodont, delivers an early therapeutic solution for tooth decay. Its revenue includes sales of dental care products. Geographically, the maximum revenue of the company is derived from the United States, and the rest from Switzerland, Italy and the United Kingdom.
Open XNYS
Fundamentals
Key company ratios and reported financial statements.
Key ratios
No ratio data was found for VVVV.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.
No quarterly income statement data was found for VVVV.
Recent news
Company coverage with links to the original publishers.
No recent company news found.
Dividends
Declared distributions and recorded event dates. Forecasts are not shown.
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.
No stock split records found.